CDK/HDAC-IN-1 is a potent inhibitor of CDK2, CDK4, CDK6, and HDAC6, with IC50 values of 60.9±2.9, 276±22.3, 27.2±4.2, and 128.6±0.4 nM, respectively; it is used as a multi-target anticancer agent targeting cell cycle regulation and histone deacetylation pathways.